Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates

Update on Immuno-Oncology Biomarkers

6/19/2019

0 Comments

 
This CME activity is provided by the American Society for Clinical Pathology (ASCP):

​​Update on Immuno-Oncology Biomarkers
​This 1 hour, interactive, online CME/CMLE module will help pathologists, laboratory professionals, and other members of the cancer care team gain deeper scientific knowledge in immuno-oncology (IO) and keep up with the rapidly evolving science of IO biomarkers including IO biomarker testing, tumor mutational burden, PD-L1 testing and interpretation, and the use of checkpoint inhibitors for treatment.
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates